Indefinite Delivery Contract 75F40120D00031

Award Date 9/24/20
Last Date to Order 9/27/23
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...
The provided information describes a Indefinite Delivery Contract (IDC) awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor Syneos Health Research & Insights LLC. The IDC has a ceiling value of $3,446,837.42 and a period of performance from May 16, 2023 to May 16, 2025. The purpose of the contract is to provide the FDA with "ACCESS TO HEALTHCARE PRACTITIONER PRESCRIBING PRACTICES DATA". This requirement was originally solicited...
The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Source Healthcare Analytics LLC with a potential value of $45 million. Under the contract, Source Healthcare will provide the FDA access to outpatient prescription and patient level drug utilization data over a five-year period ending in May 2025. Task Order 1 was issued with a firm fixed price value of $20.2 million. Source Healthcare will support the FDA's efforts...
The Indefinite Delivery Contract (IDC) with ID 75F40118D10032 was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative. The $75 million multiple-award contract aims to develop new and innovative methods for automated reporting of CBER-regulated biological products. Iqvia Government Solutions, a leading provider of healthcare data and analytics services to federal agencies, will deliver a range of...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $60 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Dun & Bradstreet Inc., doing business as Dun & Bradstreet Receivable Management Services, for database subscriptions, analytical services, and licensing. Under this contract, Dun & Bradstreet will provide the FDA with access to its commercial data and analytics to support the agency's regulatory, compliance, and...
The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through...
This federal contract IDV was awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The indefinite delivery contract, valued at up to $19,998,000, is for scientific studies and analysis in support of the FDA's Center for Drug Evaluation and Research (CDER) priority programs. It is a multiple award contract without any set-aside...
This Indefinite Delivery Contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Circana, LLC (doing business as Infoscan), a for-profit data and analytics firm. The single-award $20,001,000.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract runs from April 2, 2024 through April 1, 2029 and serves as a comprehensive vehicle for the FDA and potentially other federal partners to access Circana's consumer insights, data, and analytics services through...
  • 75F40120D00031
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Iqvia Government Solutions Inc., a prominent healthcare data and analytics provider. The contract, valued at up to $3,169,963.15, provides the FDA with access to over-the-counter (OTC) drug utilization data to strengthen the agency's drug monitoring and safety surveillance programs.

Through a series of firm fixed price delivery orders under this single-award contract, Iqvia will provide the FDA with aggregated and de-identified OTC drug transaction and demographic data. This data will support the FDA's regulatory efforts and enhance post-market surveillance of non-prescription medications used by American consumers. The contract does not have any set-aside designations, indicating Iqvia competed for this work through full and open competition. The period of performance runs through September 2023, with the initial delivery order valued at $381,366.10 and subsequent orders valued at $385,752.76 and $399,769.88. The contract's place of performance is in Falls Church, Virginia, where Iqvia is headquartered.

Generated 4/26/25, 9:46 AM